FluoGuide A/S (FLUO.ST)

SEK 37.0

(-1.99%)

Market Cap (In SEK)

503.94 Million

Revenue (In SEK)

423 Thousand

Net Income (In SEK)

-38.37 Million

Avg. Volume

9068.00

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
31.85-80.0
PE
-
EPS
-
Beta Value
1.132
ISIN
DK0061123312
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Morten Albrechtsen B.B.A., BBA, M.D.
Employee Count
-
Website
https://fluoguide.com
Ipo Date
2019-06-17
Details
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.